Chemed Total Long Term Liabilities 2010-2024 | CHE

Chemed total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
  • Chemed total long term liabilities for the quarter ending September 30, 2024 were $0.266B, a 6.11% increase year-over-year.
  • Chemed total long term liabilities for 2023 were $0.248B, a 28.29% decline from 2022.
  • Chemed total long term liabilities for 2022 were $0.346B, a 17.01% decline from 2021.
  • Chemed total long term liabilities for 2021 were $0.417B, a 77.77% increase from 2020.
Chemed Annual Total Long Term Liabilities
(Millions of US $)
2023 $248
2022 $346
2021 $417
2020 $235
2019 $279
2018 $193
2017 $186
2016 $184
2015 $168
2014 $233
2013 $81
2012 $250
2011 $237
2010 $219
2009 $206
Chemed Quarterly Total Long Term Liabilities
(Millions of US $)
2024-06-30 $266
2024-03-31 $262
2023-12-31 $248
2023-09-30 $246
2023-06-30 $251
2023-03-31 $268
2022-12-31 $346
2022-09-30 $337
2022-06-30 $343
2022-03-31 $359
2021-12-31 $417
2021-09-30 $252
2021-06-30 $246
2021-03-31 $239
2020-12-31 $235
2020-09-30 $236
2020-06-30 $222
2020-03-31 $347
2019-12-31 $279
2019-09-30 $309
2019-06-30 $252
2019-03-31 $265
2018-12-31 $193
2018-09-30 $231
2018-06-30 $205
2018-03-31 $228
2017-12-31 $186
2017-09-30 $148
2017-06-30 $189
2017-03-31 $221
2016-12-31 $184
2016-09-30 $188
2016-06-30 $224
2016-03-31 $207
2015-12-31 $168
2015-09-30 $222
2015-06-30 $246
2015-03-31 $248
2014-12-31 $233
2014-09-30 $240
2014-06-30 $240
2014-03-31 $85
2013-12-31 $81
2013-09-30 $78
2013-06-30 $79
2013-03-31 $255
2012-12-31 $250
2012-09-30 $242
2012-06-30 $241
2012-03-31 $242
2011-12-31 $237
2011-09-30 $228
2011-06-30 $226
2011-03-31 $223
2010-12-31 $219
2010-09-30 $213
2010-06-30 $211
2010-03-31 $210
2009-12-31 $206
2009-09-30 $199
2009-06-30 $197
2009-03-31 $199
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.459B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.039B 12.12
Quest Diagnostics (DGX) United States $17.877B 18.12
DaVita (DVA) United States $12.667B 16.38
Encompass Health (EHC) United States $10.405B 24.53
Elanco Animal Health (ELAN) United States $7.054B 16.79
RadNet (RDNT) United States $6.388B 141.61
Option Care Health (OPCH) United States $3.890B 18.43
Amedisys (AMED) United States $3.035B 21.60
LifeStance Health (LFST) United States $2.828B 0.00
Addus HomeCare (ADUS) United States $2.320B 27.22
Astrana Health (ASTH) United States $2.297B 36.01
U.S Physical Therapy (USPH) United States $1.428B 37.54
Pennant (PNTG) United States $1.162B 46.99
Aveanna Healthcare Holdings (AVAH) United States $1.149B 0.00
Atai Life Sciences (ATAI) Germany $0.265B 0.00
Daxor (DXR) United States $0.042B 0.00
Psychemedics (PMD) United States $0.014B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.011B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00